Business
GTX Corp Approved for Listing on the OTCQB Venture And will be Presenting at the SoCalBio Smart Wearable 2nd Annual Digital Health Conference
GTX Corp Approved for Listing on the OTCQB Venture And will be Presenting at the SoCalBio Smart Wearable 2nd Annual Digital Health Conference.
About this update from Metalert Inc
[{"type":"text","content":"\nLOS ANGELES, CALIFORNIA, Oct. 31, 2018 (GLOBE NEWSWIRE) -- GTX Corp (OTCQB: GTXO), an Internet of Things (IoT) solutions provider in the wearable GPS location and wandering assistive technology business, announced today it has received approval to be upgraded to the OTCQB Market. Beginning today GTX Corp shares will trade on the OTCQB Venture Market. To qualify companies must be current in their reporting and undergo an annual verification and management certification process. Investors will now be able to find Real-Time quotes and market information for the Company on www.otcmarkets.com.\n\n \n \n \n \n \n \n \n \n \n \n \n SoCalBio Smart Wearable\n \n \n \n \n \n \n \n \n\n GTX Corp will also be presenting at the 2018 2nd Annual SoCalBio’s Digital Health Conference which will be held November 9 at Hotel Maya in Long Beach, California. Fifteen Los Angeles based companies will showcase their latest medical-grade smart wearables for fitness, remote monitoring, elderly care, disease management and healthcare workflow. GTX Corp’s Chief Executive Officer, Patrick Bertagna, will be speaking on the “Remote Monitoring & Elderly Care” panel taking place from 11:00 AM to noon. Mr. Bertagna and other selected fellow industry experts and key opinion and thought leaders, will discuss how smart wearables can help disrupt traditional healthcare by lowering costs and expanding the reach of quality healthcare to the aging and remote population. In addition to showcasing innovative technologies developed in Southern California, including GTX’s flagship award-winning, patented GPS SmartSole, the conference will provide a forum for digital health stakeholders to discuss the current medical landscape. The full-day conference will feature keynotes on the past, present and future role of Los Angeles based wearable tech entrepreneurs. Panelists will also share their insights on design trends and the role of wearable devices in clinical research, managing chronic disease and easing the burden of an aging population. Strategies for tackling a range of challenges, from regulation and reimbursement to cybersecurity and privacy, will also be addressed. Companies presenting at the conference were chosen by the SoCalBio Innovation Catalyst Program Members via a rigorous selection process. Pre-registration is required to at...